Since MpBC is typically TNBC, analysis of available syngeneic models of this breast cancer subtype may assist in better characterizing aspects of NOS function involving the TME and impacting the clinical effects of NOS-targeted therapies. This evidence concerns the gene NOS2 and breast cancer.